Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Unclear study methods still confusing readers despite CONSORT guidelines (e.g., lidocaine patch does relieve pain of covered rib fractures).

Farr BM.

J Clin Epidemiol. 2014 Mar;67(3):356-7. doi: 10.1016/j.jclinepi.2013.07.010. Epub 2013 Sep 17. No abstract available.

PMID:
24054171
2.

Transmission of resistant bacteria in intensive care.

Farr BM, Jarvis WR.

N Engl J Med. 2011 Aug 25;365(8):762; author reply 764-5. doi: 10.1056/NEJMc1107077. No abstract available.

PMID:
21864176
3.

Prevention of surgical-site infections.

Farr BM, Jarvis WR.

N Engl J Med. 2010 Apr 22;362(16):1541; author reply 1542-4. No abstract available.

PMID:
20414961
4.

Rates of Stenotrophomonas maltophilia colonization and infection in relation to antibiotic cycling protocols.

Pakyz AL, Farr BM.

Epidemiol Infect. 2009 Dec;137(12):1679-83. doi: 10.1017/S0950268809002830.

PMID:
19874637
5.

What works and what doesn't for the control of methicillin-resistant Staphylococcus aureus infection: dogma and data.

Farr BM, Jarvis WR.

Clin Infect Dis. 2009 Sep 15;49(6):987-8; author reply 989-90. doi: 10.1086/605536. No abstract available.

PMID:
19694537
6.

Searching many guidelines for how best to control methicillin-resistant Staphylococcus aureus healthcare-associated spread and infection.

Farr BM, Jarvis WR.

Infect Control Hosp Epidemiol. 2009 Aug;30(8):808-9. doi: 10.1086/599000. No abstract available.

PMID:
19591585
7.

Why we disagree with the analysis of Wenzel et al.

Farr BM, Jarvis WR.

Infect Control Hosp Epidemiol. 2009 May;30(5):497-9; author reply 499-500. doi: 10.1086/597064. No abstract available.

PMID:
19344270
8.

Methicillin-resistant Staphylococcus aureus: misinterpretation and misrepresentation of active detection and isolation.

Farr BM, Jarvis WR.

Clin Infect Dis. 2008 Nov 1;47(9):1238-9; author reply 1239-40. doi: 10.1086/592119. No abstract available.

PMID:
18831705
9.

Universal screening for methicillin-resistant Staphylococcus aureus by hospitals.

Salgado CD, Vos MC, Farr BM.

JAMA. 2008 Aug 6;300(5):503-4; author reply 504-5. doi: 10.1001/jama.300.5.503-b. No abstract available.

PMID:
18677019
10.

Political versus epidemiological correctness.

Farr BM.

Infect Control Hosp Epidemiol. 2007 May;28(5):589-93. Epub 2007 Apr 18. Review. No abstract available.

PMID:
17464920
12.

Doing the right thing (and figuring out what that is).

Farr BM.

Infect Control Hosp Epidemiol. 2006 Oct;27(10):999-1003. Epub 2006 Sep 21. No abstract available.

PMID:
17006804
13.

Another tale of two guidelines.

Muto CA, Jarvis WR, Farr BM.

Clin Infect Dis. 2006 Sep 15;43(6):796-7;; author reply 797-8. No abstract available.

PMID:
16912962
14.

Control of nosocomial methicillin-resistant Staphylococcus aureus infection.

Muto CA, Vos MC, Jarvis WR, Farr BM.

Clin Infect Dis. 2006 Aug 1;43(3):387-8. No abstract available.

PMID:
16804860
15.

Cognitive effects of diarrhea, malnutrition, and Entamoeba histolytica infection on school age children in Dhaka, Bangladesh.

Tarleton JL, Haque R, Mondal D, Shu J, Farr BM, Petri WA Jr.

Am J Trop Med Hyg. 2006 Mar;74(3):475-81.

PMID:
16525109
16.
17.

Entamoeba histolytica infection in children and protection from subsequent amebiasis.

Haque R, Mondal D, Duggal P, Kabir M, Roy S, Farr BM, Sack RB, Petri WA Jr.

Infect Immun. 2006 Feb;74(2):904-9.

18.

Prevention and control of antimicrobial-resistant infections in intensive care patients.

Salgado CD, O'Grady N, Farr BM.

Crit Care Med. 2005 Oct;33(10):2373-82. Review.

PMID:
16215395
19.

Positive predictive value of a percutaneously drawn blood culture growing skin flora varies markedly by organism.

Geffers C, Farr BM.

Infect Control Hosp Epidemiol. 2005 Jun;26(6):507-9. No abstract available.

PMID:
16018422
20.

Has methicillin-resistant Staphylococcus aureus stopped spreading in intensive care units?

Muto CA, Farr BM, Jarvis WR.

Clin Infect Dis. 2005 Jul 15;41(2):269-70; author reply 270-1. No abstract available.

PMID:
15983929
21.

Risk of transmission of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) from patients colonized with MRSA.

Geffers C, Farr BM.

Infect Control Hosp Epidemiol. 2005 Feb;26(2):114-5. No abstract available.

PMID:
15756878
22.

Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians.

Salgado CD, Giannetta ET, Hayden FG, Farr BM.

Infect Control Hosp Epidemiol. 2004 Nov;25(11):923-8.

PMID:
15566025
23.

Prevention and control of methicillin-resistant Staphylococcus aureus infections.

Farr BM.

Curr Opin Infect Dis. 2004 Aug;17(4):317-22. Review.

PMID:
15241075
24.

Failure to develop vancomycin-resistant Enterococcus with oral vancomycin treatment of Clostridium difficile.

Salgado CD, Giannetta ET, Farr BM.

Infect Control Hosp Epidemiol. 2004 May;25(5):413-7.

PMID:
15188848
26.

Community-acquired methicillin-resistant Staphylococcus aureus.

Salgado CD, Farr BM.

JAMA. 2004 Apr 28;291(16):1960-1; author reply 1961. No abstract available.

PMID:
15113812
27.

For nosocomial vancomycin-resistant enterococcal infections: the ounce of prevention or the pound of cure?

Farr BM.

Clin Infect Dis. 2004 Apr 15;38(8):1116-8. Epub 2004 Apr 5. No abstract available.

PMID:
15095216
28.

The state of the science.

Farr BM.

Am J Infect Control. 2004 Apr;32(2):106-13. Review. No abstract available.

PMID:
15057203
29.

Volume 25: An important milestone despite continuing infection control challenges.

Farr BM.

Infect Control Hosp Epidemiol. 2004 Jan;25(1):7-9. No abstract available.

PMID:
14756212
30.

Influence of human leukocyte antigen class II alleles on susceptibility to Entamoeba histolytica infection in Bangladeshi children.

Duggal P, Haque R, Roy S, Mondal D, Sack RB, Farr BM, Beaty TH, Petri WA Jr.

J Infect Dis. 2004 Feb 1;189(3):520-6. Epub 2004 Jan 20.

PMID:
14745711
31.

Catheters, microbes, time, and gold standards.

Farr BM.

Ann Intern Med. 2004 Jan 6;140(1):62-4. No abstract available.

PMID:
14706975
32.

Epidemiologic and clinical characteristics of acute diarrhea with emphasis on Entamoeba histolytica infections in preschool children in an urban slum of Dhaka, Bangladesh.

Haque R, Mondal D, Kirkpatrick BD, Akther S, Farr BM, Sack RB, Petri WA Jr.

Am J Trop Med Hyg. 2003 Oct;69(4):398-405.

PMID:
14640500
33.

Outcomes associated with vancomycin-resistant enterococci: a meta-analysis.

Salgado CD, Farr BM.

Infect Control Hosp Epidemiol. 2003 Sep;24(9):690-8.

PMID:
14510253
34.

SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus.

LeDell K, Muto CA, Jarvis WR, Farr BM.

Infect Control Hosp Epidemiol. 2003 Sep;24(9):639-41. No abstract available.

PMID:
14510243
35.

A pseudo-outbreak of nosocomial infections associated with the introduction of an antibiotic management programme.

Calfee DP, Brooks J, Zirk NM, Giannetta ET, Scheld WM, Farr BM.

J Hosp Infect. 2003 Sep;55(1):26-32.

PMID:
14505606
36.

Ultraviolet light disinfection of hospital water for preventing nosocomial Legionella infection: a 13-year follow-up.

Hall KK, Giannetta ET, Getchell-White SI, Durbin LJ, Farr BM.

Infect Control Hosp Epidemiol. 2003 Aug;24(8):580-3.

PMID:
12940578
37.

Three, if by air.

Sepkowitz KA, Farr BM.

Infect Control Hosp Epidemiol. 2003 Jul;24(7):470-1. No abstract available.

PMID:
12887232
38.

Control of endemic vancomycin-resistant Enterococcus among inpatients at a university hospital.

Calfee DP, Giannetta ET, Durbin LJ, Germanson TP, Farr BM.

Clin Infect Dis. 2003 Aug 1;37(3):326-32. Epub 2003 Jul 14.

PMID:
12884155
39.

Spread of methicillin-resistant Staphylococcus aureus (MRSA) among household contacts of individuals with nosocomially acquired MRSA.

Calfee DP, Durbin LJ, Germanson TP, Toney DM, Smith EB, Farr BM.

Infect Control Hosp Epidemiol. 2003 Jun;24(6):422-6.

PMID:
12828318
40.

SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.

Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, Farr BM; SHEA.

Infect Control Hosp Epidemiol. 2003 May;24(5):362-86. Review.

PMID:
12785411
41.

Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors.

Salgado CD, Farr BM, Calfee DP.

Clin Infect Dis. 2003 Jan 15;36(2):131-9. Epub 2003 Jan 3.

PMID:
12522744
42.

Isoniazid-resistant cavitary tuberculosis in a physician following isoniazid prophylaxis.

Karchmer TB, Phipps JD, Giannetta ET, Farr BM.

Infect Control Hosp Epidemiol. 2002 Oct;23(10):622-5.

PMID:
12400895
43.

Innate and acquired resistance to amebiasis in bangladeshi children.

Haque R, Duggal P, Ali IM, Hossain MB, Mondal D, Sack RB, Farr BM, Beaty TH, Petri WA Jr.

J Infect Dis. 2002 Aug 15;186(4):547-52. Epub 2002 Jul 19.

PMID:
12195383
44.

Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus.

Muto CA, Giannetta ET, Durbin LJ, Simonton BM, Farr BM.

Infect Control Hosp Epidemiol. 2002 Aug;23(8):429-35.

PMID:
12186207
45.

Infection control and cost control in the era of managed care.

Calfee DP, Farr BM.

Infect Control Hosp Epidemiol. 2002 Jul;23(7):407-10. No abstract available.

PMID:
12138983
46.
47.

Low rate of false-positive results with use of a rapid HIV test.

Salgado CD, Flanagan HL, Haverstick DM, Farr BM.

Infect Control Hosp Epidemiol. 2002 Jun;23(6):335-7.

PMID:
12083238
48.

Mupirocin to prevent S. aureus infections.

Farr BM.

N Engl J Med. 2002 Jun 13;346(24):1905-6. No abstract available.

PMID:
12063377
49.

Duration of colonization with vancomycin-resistant Enterococcus.

Byers KE, Anglim AM, Anneski CJ, Farr BM.

Infect Control Hosp Epidemiol. 2002 Apr;23(4):207-11.

PMID:
12002235

Supplemental Content

Support Center